|
Re: Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
6
|
Resverlogix Corp.
|
Jul 29, 2020 12:34PM
|
|
Re: Epigenetics
|
10
|
Resverlogix Corp.
|
Feb 13, 2022 05:48PM
|
|
Re: Epigenetics and Coronavirus
|
4
|
Resverlogix Corp.
|
Mar 23, 2020 08:56AM
|
|
Re: Epigenetics and Coronavirus
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 09:57AM
|
|
Re: Epigenetics and Coronavirus
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 03:34PM
|
|
Re: Epigenetics and Coronavirus
|
5
|
Resverlogix Corp.
|
Mar 23, 2020 03:46PM
|
|
Re: Estimated Glomerular Filtration Rate
|
5
|
Resverlogix Corp.
|
Nov 17, 2019 05:51PM
|
|
Re: Estimated Glomerular Filtration Rate
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 06:22PM
|
|
Re: Expiring Warrants
|
7
|
Resverlogix Corp.
|
Jun 27, 2021 06:56PM
|
|
Re: FDA greenlights Eli Lilly COVID-19 combo therapy
|
9
|
Resverlogix Corp.
|
Mar 10, 2021 08:23PM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Aug 07, 2020 04:38PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
May 26, 2020 04:54PM
|
|
Re: Finance
|
9
|
Resverlogix Corp.
|
May 25, 2020 05:48PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Aug 10, 2020 07:54PM
|
|
Re: Fireside Chat
|
3
|
Resverlogix Corp.
|
Oct 11, 2020 04:50PM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
7
|
Resverlogix Corp.
|
Jul 07, 2020 07:40PM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
4
|
Resverlogix Corp.
|
Jul 27, 2020 08:05PM
|
|
Re: Forest plot
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 12:55PM
|
|
Re: from J4P on SH “ "I will go out on a limb with a prediction, but please follow my line of reasoning”
|
1
|
Resverlogix Corp.
|
Mar 06, 2021 01:04PM
|
|
Re: from J4P on SH “ "I will go out on a limb with a prediction, but please follow my line of reasoning”
|
6
|
Resverlogix Corp.
|
Mar 05, 2021 04:27PM
|
